Vascular Access Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

The market is expected to grow at a steady CAGR forecast till 2030 owing to growing prevalence of chronic diseases and technological advancements in vascular access devices.

The vascular access devices market was valued at USD 4.59 billion in 2023, growing at a CAGR of 6.64% during the forecast period from 2024 to 2030, to reach USD 6.75 billion by 2030. The demand for vascular access devices is primarily motivated by the growing prevalence of chronic diseases such as cancer, chronic kidney disease, and heart diseases that require the use of these devices. Technological advancements in vascular access devices and the growing aging population which require frequent medical treatment and hospitalization may drive the growth of the market.

Vascular Access Devices Market Dynamics:

The growth of the vascular access devices market is driven by several key factors, including the rising prevalence of chronic diseases such as cancer, diabetes, and cardiovascular conditions, which often require long-term intravenous treatments. Increased demand for minimally invasive procedures and advancements in vascular access technologies, such as the development of antimicrobial catheters and ultrasound-guided insertion techniques, are further fueling market expansion. Additionally, the growing geriatric population, which is more prone to conditions requiring frequent vascular access for therapies like dialysis and chemotherapy, contributes to the increasing adoption of these devices. Moreover, the emphasis on reducing healthcare-associated infections (HAIs) and improving patient outcomes is promoting the use of safer, more efficient vascular access solutions.

Cancer is one of the leading chronic diseases impacting populations globally. According to data from GLOBOCAN 2024, approximately 20 million new cancer cases were reported in 2022, with projections estimating that this number could rise to 35 million by 2050. Vascular access devices play a crucial role in chemotherapy procedures, which are commonly used in cancer treatment, thereby driving market growth. Additionally, the Centers for Disease Control and Prevention (CDC) reported in February 2024 that around 129 million people in the United States were living with at least one major chronic disease, including heart disease, cancer, diabetes, obesity, and hypertension. These factors collectively drive the ongoing growth of the vascular access devices market.

However, factors such as incorrect placement of vascular access devices and complications like infection and phlebitis may present challenges, potentially limiting market growth.

Vascular Access Devices Market Segment Analysis:

Vascular Access Devices by Device Type (Central Vascular Access Devices {Peripherally Inserted Central Catheters, Non-Tunneled Catheters, Others}, and Peripheral Vascular Access Devices {Peripheral Catheter, Midline Catheter (short) Devices, Others}), Route of Insertion (Intravenous, Subcutaneous), End-User (Hospitals, Ambulatory Surgical Centres, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the vascular access devices market, central vascular access devices are anticipated to hold the largest share in 2023, primarily due to their widespread use in chemotherapy and treatments for cardiovascular and chronic kidney disorders. The increasing prevalence of chronic diseases, which often require prolonged hospitalization, is driving demand for these devices, as they provide long-term access for medication delivery. This functionality significantly contributes to the growth of this segment.

Central vascular access devices come in various types, including peripherally inserted central catheters (PICCs) and non-tunneled catheters, among others. PICCs are gaining traction as they can be easily inserted through veins like the basilic, brachial, or cephalic, offering a minimally invasive option for long-term access.

Key players are actively forming partnerships to reduce complications and enhance vascular access procedures through advanced technologies and clinical support. For example, in September 2021, Access Vascular, Inc. entered into a strategic partnership with the Association for Vascular Access (AVA) to improve patient outcomes by promoting evidence-based practices and providing comprehensive clinical education on advanced technologies. Such collaborations are expected to propel market growth further.

Therefore, the rising prevalence of chronic diseases, coupled with advancements in technology and strategic partnerships, are key drivers anticipated to fuel growth in this segment, thereby contributing to the overall expansion of the vascular access devices market.

North America is expected to dominate the overall vascular access devices market:

North America is expected to dominate the global vascular access devices market during the forecast period, driven by the growing demand for advanced technologies and the increasing need to manage chronic diseases in the region. The rising prevalence of end-stage renal disease (ESRD) and chronic kidney disease (CKD) has significantly contributed to market growth, as vascular access devices are critical for hemodialysis and kidney dialysis procedures. According to data from the Centers for Disease Control and Prevention (CDC) in May 2024, approximately 35.5 million adults in the United States - around 14% of the total population - were living with chronic kidney disease in 2023. The increasing number of dialysis treatments necessitates greater usage of vascular access devices, further boosting market expansion.

Product innovation and commercialization activities by key players in North America are also driving market growth. For instance, in November 2023, BD launched a vascular access ultrasound system designed to improve the insertion process for devices like peripherally inserted central catheters (PICCs) and central venous catheters through real-time needle tracking. The development of such advanced technologies is expected to enhance the clinical efficiency of vascular access procedures and contribute to market growth.

Additionally, Europe and the Asia-Pacific regions present future growth opportunities for the vascular access devices market. Data from the Organisation for Economic Co-operation and Development (OECD) in December 2022 revealed that 36% of individuals aged 65 and over in EU countries had at least two chronic diseases in 2020. The rising burden of chronic diseases across European and Asian nations is fueling demand for vascular access devices, positioning these regions for significant market growth in the coming years.

Vascular Access Devices Market Key Players:

Some of the key market players operating in the vascular access devices market include Cook, BD, Teleflex Incorporate, Medtronic, Asahi Kasei Corporation, B. Braun SE, PRODiMED, AMECATH, Terumo Corporation, AngioDynamics, ICU Medical, Inc., Nipro Medical Corporation, Medline Industries, LP, Access Vascular, Inc., Vygon Group, Cordis, Merit Medical Systems, Cardinal Health, Fresenius SE & Co. KGaA, Argon Medical Devices, and others.

Recent Developmental Activities in the Vascular Access Devices Market:

• In March 2024, B. Braun Se launched the Introcan Safety 2 IV Catheter. This vascular access device is designed to reduce the chance of blood-borne infection with blood control features and reduce needlestick injuries in patients.
• In January 2022, ICU Medical, Inc. completed the acquisition of Smiths Medical for an amount of USD 1.85 billion. Through his acquisition, ICU Medical expanded its product portfolio in syringe and ambulatory infusion devices, vascular access, and vital care products to increase its global presence.
• In August 2021, PuraCath Medical™, a venture-backed startup company focusing on the development of technologies to reduce infections in patients with intravascular catheters, announced that it has received 510(k) clearance for its FireFly™ Needleless Connector from the US Food and Drug Administration (FDA). The Firefly™ Needleless Connector is a sterile single-patient-use connector for needleless access to the IV line and IV catheter during IV therapy and can be used for direct injection, intermittent infusion, continuous infusion, or aspiration. This regulatory determination by the FDA gives PuraCath clearance to market the FireFly™ needleless connector in the US.
• In July 2021, Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and structural heart markets, announced it has completed enrolment in its first-in-human study evaluating the company's Amplifi™ Vein Dilation System. The Amplifi System is designed to stimulate arm vein enlargement in hemodialysis patients using rapid, non-pulsatile venous blood flow. Novel vein dilation system aims to improve vascular access for hemodialysis patients.

Key Takes Away From the Vascular Access Devices Market Report Study

• Market size analysis for current Vascular Access Devices market size (2023), and market forecast for 6 years (2024 to 2030)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
• Key companies dominating the Vascular Access Devices Market.
• Various opportunities available for the other competitors in the Vascular Access Devices Market space.
• What are the top-performing segments in 2023? How these segments will perform in 2030.
• Which are the top-performing regions and countries in the current Vascular Access Devices market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for Vascular Access Devices market growth in the coming future?

Target Audience who can be benefited from this Vascular Access Devices Market Report Study

• Vascular Access Devices providers
• Research organizations and consulting companies
• Vascular Access Devices related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in Vascular Access Devices
• Various End-users want to know more about the Vascular Access Devices Market and the latest technological developments in the Vascular Access Devices market.

Frequently Asked Questions for Vascular Access Devices Market:

1. What are Vascular Access Devices?

• Vascular access devices are types of equipment that are inserted inside the body through a vein to enable the administration of fluids, blood products, medication, and other therapies to the bloodstream. These devices allow repeated and long-term access to the bloodstream for frequent or regular administration of drugs, like intravenous (IV) antibiotics. The vascular access tubes are made of silicone, latex, and other substances.

2. What is the market for Vascular Access Devices?

• The vascular access devices market was valued at USD 4.59 billion in 2023, growing at a CAGR of 6.64% during the forecast period from 2024 to 2030, to reach USD 6.75 billion by 2030.

3. What are the drivers for Vascular Access Devices?

• The major drivers driving the demand for Vascular Access Devices are the growing prevalence of chronic diseases such as cancer, chronic kidney disease, and heart diseases that require the use of these devices. Technological advancements in vascular access devices and the growing aging population which require frequent medical treatment and hospitalization may drive the growth of the market.

4. What are the key players operating in Vascular Access Devices?

• Some of the key market players operating in the vascular access devices market include Cook, BD, Teleflex Incorporate, Medtronic, Asahi Kasei Corporation, B. Braun SE, PRODiMED, AMECATH, Terumo Corporation, AngioDynamics, ICU Medical, Inc., Nipro Medical Corporation, Medline Industries, LP, Access Vascular, Inc., Vygon Group, Cordis, Merit Medical Systems, Cardinal Health, Fresenius SE & Co. KGaA, Argon Medical Devices, and others.

5. What regions have the highest share in the Vascular Access Devices market?

• North America is expected to dominate the global vascular access devices market during the forecast period, driven by the growing demand for advanced technologies and the increasing need to manage chronic diseases in the region. The rising prevalence of end-stage renal disease (ESRD) and chronic kidney disease (CKD) has significantly contributed to market growth, as vascular access devices are critical for hemodialysis and kidney dialysis procedures. According to data from the Centers for Disease Control and Prevention (CDC) in May 2024, approximately 35.5 million adults in the United States - around 14% of the total population - were living with chronic kidney disease in 2023. The increasing number of dialysis treatments necessitates greater usage of vascular access devices, further boosting market expansion.

This product will be delivered within 2 business days.